Talia Puzantian, PharmD, BCPP
Clinical psychopharmacology consultant in private practice, Los Angeles, CA. www.taliapuzantian.comDr. Puzantian has disclosed that she has no relevant relationships or financial interests in any commercial company pertaining to this educational activity.Daniel Carlat, MD
Editor-in-Chief, Publisher, The Carlat Report.
Dr. Carlat has disclosed that he has no relevant relationships or financial interests in any commercial company pertaining to this educational activity.
In January of this year, the FDA approved the stimulant lisdexamfetamine (Vyvanse) as the first drug with an indication for binge eating disorder (BED). Patients are hearing the buzz and may be asking you to prescribe it, but you may have some questions first.
Dr. Eissenberg discusses e-cigarettes, including an overview of the product, ways they are used and misused, and how they fit into the landscape of smoking cessation methods.
Quitting smoking requires a lot of motivation—something our patients don’t always have. Since money is a great motivator, various programs that pay patients to quit have been tried over the years. But how well does this technique work?
Learn about Trauma Systems Therapy (TST) and its use with young patients in an interview with Glenn Saxe, MD, Arnold Simon professor and chair, Department of Child and Adolescent Psychiatry, and director, the Child Study Center.
Autism is fairly common and is extremely hard to treat. A couple of antipsychotics (Risperdal, Abilify) can help decrease the agitation common in autism, and some behavior therapies can improve the ability to interact with others. But these behavioral techniques have only been studied in the short term—which is not very helpful, because autism is a long term problem.
Daniel Carlat, MD
Editor-in-Chief, Publisher, The Carlat Report.
Dr. Carlat has disclosed that he has no relevant relationships or financial interests in any commercial company pertaining to this educational activity.
There are plenty of ways that we use technology in psychiatric practice these days—including e-prescribing, electronic health records, referring patients to websites for psychoeducation, etc. But when was the last time you referred a patient to their computer for psychotherapy? Well, it may be time to consider it.
Scott Miller, PhD
Founder and Director, International Center for Clinical Excellence
Dr. Miller has disclosed that he receives payments for licensing outcome measures for use by clinicians. Dr. Carlat has reviewed this interview and found no evidence of bias in this educational activity.
Get advice on how you can become a top-performing clinician, including how to put processes in place to consistently get feedback from your patients, in an interview with Scott D. Miller, PhD, found and director of the International Center for Clinical Excellence.
Kenneth N. Levy, PhD
Associate Professor of Psychology, Pennsylvania State University, Associate Director of Research, Personality Disorders Institute at Cornell University
Dr. Levy has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.Jay Coburn, MA, MS
Mr. Coburn conducted this interview. He is a case coordinator at the Cape Ann Adult Behavioral Learning Center in Beverly, Mass.
He has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.
Learn about the use of transference-focused psychotherapy to treat personality disorders, in an interview with Kenneth N. Levy, PhD, from the Personality Disorders Institute at Cornell University.